has been cited by the following article(s):
|
[1]
|
COVID-19 Pandemic, Part III: Assessment
Voice of the Publisher,
2024
DOI:10.4236/vp.2024.101002
|
|
|
|
|
[2]
|
COVID-19 Pandemic, Part I: What to Do and Who to Blame? Susceptibility to Viral Infection via Jeopardized Immunity
International Journal of Analytical Mass Spectrometry and Chromatography,
2020
DOI:10.4236/ijamsc.2020.82002
|
|
|
|
|
[3]
|
Super Antibiotics: Part III. Hyperforin, Revision of the Relative and Absolute Stereochemistry Presented by Bystrov et al.
Voice of the Publisher,
2017
DOI:10.4236/vp.2017.32002
|
|
|
|
|
[4]
|
To Be or Not to Be…? Part I: Is Global Climate Change a Future Reality?
Voice of the Publisher,
2017
DOI:10.4236/vp.2017.33003
|
|
|
|
|
[5]
|
Super Antibiotics: Part V. Doxycycline
Voice of the Publisher,
2017
DOI:10.4236/vp.2017.34006
|
|
|
|
|
[6]
|
Super Antibiotics, Part II. Hyperforin, Mass Spectroscopy (MS) and Gas Chromatography-Mass Spectrometry (GC-MS), Evidence of Permeability of the Blood-Testis Barrier (BTB) and the Blood-Brain Barrier (BBB) to Hyperforin
International Journal of Analytical Mass Spectrometry and Chromatography,
2016
DOI:10.4236/ijamsc.2016.44007
|
|
|
|